Nicola Veronese1, Brendon Stubbs2, Marco Solmi3, Alberto Vaona4, Jacopo Demurtas5, Andre F Carvalho6, Ai Koyanagi7, Trevor Thompson8, Mario Zoratti9, Stefania Maggi10. 1. National Research Council, Neuroscience Institute, Aging Branch, Padova, Italy; Institute for clinical Research and Education in Medicine (IREM), Padova, Italy. Electronic address: ilmannato@gmail.com. 2. South London and Maudsley NHS Foundation Trust, Denmark Hill, London SE5 8AZ, United Kingdom; Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8 AF, United Kingdom; Faculty of Health, Social Care and Education, Anglia Ruskin University, Chelmsford, United Kingdom. 3. Institute for clinical Research and Education in Medicine (IREM), Padova, Italy; Department of Neurosciences, University of Padova, Padova, Italy. 4. Primary Care Department, Azienda ULSS20 Verona, Verona, Italy. 5. Primary Care Department, Azienda USL Toscana Sud Est, Grosseto, Italy. 6. Translational Psychiatry Research Group, Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil. 7. Research and Development Unit, Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, CIBERSAM, Barcelona, Spain. 8. Faculty of Education and Health, University of Greenwich, London, United Kingdom. 9. National Research Council, Neuroscience Institute, Aging Branch, Padova, Italy; Department of Biomedical Sciences, University of Padova, Padova, Italy. 10. National Research Council, Neuroscience Institute, Aging Branch, Padova, Italy.
Abstract
BACKGROUND: A possible relationship between mitochondrial haplogroups and psychiatric diseases (e.g. schizophrenia and bipolar disorder) has been postulated, but data regarding depression is still limited. We investigated whether any mitochondrial haplogroup carried a significant higher risk of depressive symptoms in a large prospective cohort of North American people included in the Osteoarthritis Initiative. METHODS: Cross sectional data was derived from the Osteoarthritis Initiative. The haplogroup was assigned through a combination of sequencing and PCR-RFLP techniques. All the mitochondrial haplogroups were named following this nomenclature: H, U, K, J, T, V, SuperHV, I, W, X or Others. Depression was ascertained through the 20-item Center for Epidemiologic Studies-Depression (CES-D), with ≥16 indicating depressive symptoms. RESULTS: Overall, 3601 Caucasian participants (55.9% women), mean age of 61.7±9.3 years were included. No difference was observed in mitochondrial haplogroups frequency among those with depressive symptoms (n=285, =7.9% of the baseline population) compared to participants with no depressive symptoms (N=3316) (chi-square test=0.53). Using a logistic regression analysis, adjusted for eight potential confounders, with those having the haplogroup H as the reference group (the most common haplogroup), no significant mitochondrial haplogroup was associated with prevalent depressive symptoms. The same results were evident in secondary analysis in which we matched depressed and non-depressed participants for age and sex. LIMITATIONS: Cross-sectional design; only CES-D for evaluating mood; participants not totally representative of general population. CONCLUSIONS: We found no evidence of any relationship between specific mitochondrial haplogroups and depressive symptoms. Future longitudinal research is required to confirm/ refute these findings.
BACKGROUND: A possible relationship between mitochondrial haplogroups and psychiatric diseases (e.g. schizophrenia and bipolar disorder) has been postulated, but data regarding depression is still limited. We investigated whether any mitochondrial haplogroup carried a significant higher risk of depressive symptoms in a large prospective cohort of North American people included in the Osteoarthritis Initiative. METHODS: Cross sectional data was derived from the Osteoarthritis Initiative. The haplogroup was assigned through a combination of sequencing and PCR-RFLP techniques. All the mitochondrial haplogroups were named following this nomenclature: H, U, K, J, T, V, SuperHV, I, W, X or Others. Depression was ascertained through the 20-item Center for Epidemiologic Studies-Depression (CES-D), with ≥16 indicating depressive symptoms. RESULTS: Overall, 3601 Caucasian participants (55.9% women), mean age of 61.7±9.3 years were included. No difference was observed in mitochondrial haplogroups frequency among those with depressive symptoms (n=285, =7.9% of the baseline population) compared to participants with no depressive symptoms (N=3316) (chi-square test=0.53). Using a logistic regression analysis, adjusted for eight potential confounders, with those having the haplogroup H as the reference group (the most common haplogroup), no significant mitochondrial haplogroup was associated with prevalent depressive symptoms. The same results were evident in secondary analysis in which we matched depressed and non-depressed participants for age and sex. LIMITATIONS: Cross-sectional design; only CES-D for evaluating mood; participants not totally representative of general population. CONCLUSIONS: We found no evidence of any relationship between specific mitochondrial haplogroups and depressive symptoms. Future longitudinal research is required to confirm/ refute these findings.
Authors: Jérôme Nicod; Stefanie Wagner; Frederick Vonberg; Amarjit Bhomra; Konrad F Schlicht; Andre Tadic; Richard Mott; Klaus Lieb; Jonathan Flint Journal: Biol Psychiatry Date: 2015-12-30 Impact factor: 13.382
Authors: A Karabatsiakis; C Böck; J Salinas-Manrique; S Kolassa; E Calzia; D E Dietrich; I-T Kolassa Journal: Transl Psychiatry Date: 2014-06-10 Impact factor: 6.222
Authors: D Lindqvist; J Fernström; C Grudet; L Ljunggren; L Träskman-Bendz; L Ohlsson; Å Westrin Journal: Transl Psychiatry Date: 2016-12-06 Impact factor: 6.222